Scholar Rock Gets FDA Approval of Isembyld for Spinal Muscular Atrophy
By Josh BeckermanScholar Rock said the Food and Drug Administration approved Isembyld, or apitegromab, for the treatment of spinal muscular atrophy.The drug was approved for adults and for children two years of age and older who are currently receiving a survival motor neuron 2-targeted treatment.S…